|
|
Overview
Understanding your industry
Highly regulated and closely monitored, the industry is characterised by:
-
complex regulatory frameworks
-
lengthy premarket development periods and licensing regimes
-
the importance of the development, ownership and protection of technology, and
-
high levels of investment.
Our team understands the drivers for participants in this industry sector. We have lawyers who are experienced in all phases of the industry from assisting “start-up” and smaller companies in research and development, capital raisings and the commercialisation and protection of intellectual property through to assisting well-established multinationals with compliance with Therapeutic Goods and Trade Practices legislation and protection of their intellectual property. Our experience in the resolution of tender and contracting issues with government at all levels, the financing of large scale operations, and experience in the acquisition and disposal of businesses in this sector enhance our ability to add value to industry participants.
How we can help
Our services include:
-
advice on veterinary laws
-
commercial advice
-
compliance programs and risk management
-
enforcement of patent, trade mark, design, copyright and confidential information rights
-
government tendering and probity advice
-
marketing, packaging and comparative advertising advice
-
medical malpractice and disciplinary
-
medical products and services insurance
-
product development and innovation
-
product recalls and product liability
-
regulatory and administrative advice including TGA and TPA
-
trade mark registration and portfolio management
-
Trade Practices advice and compliance programs.
Industry participation
DibbsBarker is a member of AusBiotech - Australia’s Biotechnology Industry Association representing human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in Biotechnology http://www.ausbiotech.org.
Lis Boyce, Partner and Leader of the DibbsBarker Medical & Pharmaceutical Industry Group is also Chairperson of the NSW Committee of AusMedtech. AusMedtech is dedicated to the advancement of the Australian medical technology industry as a division of AusBiotech. In addition, Beth McIntyre, a Special Counsel in the Medical & Pharmaceutical Industry Group is on the Health Economics Expert Panel for AusMedtech.

|
|
IAM Licensing 250
Rob McInnes, partner, named as Australia's highest recommended patent and technology licensing lawyer in the IAM Licensing 250. For more information on how the DibbsBarker Intellectual Property & Technology Group can assist your business, please contact Rob McInnes. |
|
Best Lawyers Australia 2012
Group member Andrew Saxton was judged by his peers to be Sydney's top lawyer in the category of Health and Aged Care in 2012 and in Medical Negligence in 2011 . . . more |
|